Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Csemiczky, G.
Right arrow Articles by Britt-Marie, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Csemiczky, G.
Right arrow Articles by Britt-Marie, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 11, No. 11, pp. 2396-2399, 1996
© 1996 European Society of Human Reproduction and Embryology

research-article

Endocrinology: Luteal phase oestradiol and progesterone levels are stronger predictors than follicular phase follicle stimulating hormone for the outcome of in-vitro fertilization treatment in women with tubal infertility

György Csemiczky, Håan Wramsby1 and Landgren Britt-Marie

Department of Woman and Child Health, Division for Obstetrics & Gynecology, Karolinska Hospital PO Box 140, S-171 76 Stockholm, Sweden

Correspondence: 1To whom correspondence should be addressed

Basal follicle stimulating hormone (FSH) in a natural cycle, FSH on cycle days 3 and 10 in a domiphene citrate-stimulated cycle and oestradiol and progesterone area under the curve (AUC) in the luteal phase of the ciomiphene citrate-stimulated cycle were evaluated as hormonal predictors for the outcome of FVF treatment in 53 normally cycling women with tubal infertility. The pregnant women had significantly fewer treatment cycles (P < 0.001) and needed fewer ampoules of gonadotrophins (P < 0.001). They also had more oocyte retrievals (P < 0.001), more oocytes per retrieval (P < 0.01), higher fertilization rate (P < 0.001) and more replaced pre-embryos per replacement (P < 0.01) as compared with non-pregnant women. Significant differences were found in FSH concentrations on cycle days 3 (P < 0.05) and 10 (P < 0.001) after domiphene citrate stimulation and for oestradiol and progesterone AUC in the luteal phase (P < 0.001) between those women who became pregnant and those who did not become pregnant after IVF treatment Luteal oestradiol and progesterone had considerably stronger predictive value for the outcome of IVF treatment as compared to basal FSH and domiphene citrate challenge test.

Key words: follicle stimulating hormone/IVF outcome/oestradiol/pregnancy/progesterone


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk
A systematic review of tests predicting ovarian reserve and IVF outcome
Hum. Reprod. Update, November 1, 2006; 12(6): 685 - 718.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P.S. Bhal, N.D. Pugh, D.K. Chui, L. Gregory, S.M. Walker, and R.W. Shaw
The use of transvaginal power Doppler ultrasonography to evaluate the relationship between perifollicular vascularity and outcome in in-vitro fertilization treatment cycles
Hum. Reprod., April 1, 1999; 14(4): 939 - 945.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.